Literature DB >> 24102414

Distinct genetic aberrations in oesophageal adeno and squamous carcinoma.

Ramaswamy Pandilla1, Viswakalyan Kotapalli, Swarnalata Gowrishankar, MohanaVamsy Chigurupati, Sujith Patnaik, Shantveer Uppin, Subramanyeshwar Rao, Narasimharaju Kalidindi, Sastry Regulagadda, Challa Sundaram, Mukta Srinivasulu, Anjayneyulu Vasala, Murali Dharan Bashyam.   

Abstract

BACKGROUND: The two main oesophageal cancer subtypes namely adenocarcinoma and squamous cell carcinoma exhibit interesting clinical, pathological and geographical variations with the former being more common in the West and the latter in Asia.
MATERIALS AND METHODS: We evaluated status of p53, EGFR, Wnt and HPV in addition to microsatellite instability and loss of heterozygosity of several chromosomal loci in the two oesophageal cancer subtypes from India. The comparative analysis was extended to two oesophageal adenosquamous mixed cancer samples.
RESULTS: Our results reveal a high frequency of EGFR overexpression in ESCC as against EAC, while Wnt activation was a significantly more common event in EAC as against ESCC. Frequencies of p53 perturbations were not significantly different in the two subtypes. Interestingly, the EGFR and Wnt status in adenocarcinoma and squamous components of the two oesophageal adenosquamous cancer samples were identical to primary tumours. In addition, no common molecular aberration (including instability and loss of heterozygosity) in several microsatellites was detected in DNA isolated from the two components in both adenosquamous cancer samples.
CONCLUSIONS: Our results reveal the presence of distinct aberrations in oesophageal adenocarcinoma and squamous cell carcinoma which are replicated in the respective components of adenosquamous cancers. The study therefore suggests perhaps an independent origin of the two components of oesophageal adenosquamous mixed cancer.
© 2013 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Adenosquamous mixed cancers; EGFR; Wnt; esophageal adenocarcinoma; esophageal squamous cell carcinoma; p53

Mesh:

Substances:

Year:  2013        PMID: 24102414     DOI: 10.1111/eci.12163

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  10 in total

1.  Identification of Adenosquamous Carcinoma as a Rare Aggressive HER2-negative Subgroup of Esophageal/Gastroesophageal Junction Adenocarcinoma.

Authors:  Zhaohui Jin; Marie Holubek; William R Sukov; Christopher A Sattler; Anne E Wiktor; Robert B Jenkins; Tsung-Teh Wu; Harry H Yoon
Journal:  Am J Clin Oncol       Date:  2019-02       Impact factor: 2.339

Review 2.  The promise of PD-1 inhibitors in gastro-esophageal cancers: microsatellite instability vs. PD-L1.

Authors:  Zhaohui Jin; Harry H Yoon
Journal:  J Gastrointest Oncol       Date:  2016-10

3.  Metadherin contributes to the pathogenesis of chronic lymphocytic leukemia partially through Wnt/β-catenin pathway.

Authors:  Pei-Pei Li; Li-Li Feng; Na Chen; Xue-Ling Ge; Xiao Lv; Kang Lu; Mei Ding; Dai Yuan; Xin Wang
Journal:  Med Oncol       Date:  2015-01-10       Impact factor: 3.064

4.  Increased Wnt Signaling and Reduced Viability in a Neuronal Model of Progranulin-Deficient Frontotemporal Lobar Degeneration.

Authors:  Ana de la Encarnación; Carolina Alquézar; Ángeles Martín-Requero
Journal:  Mol Neurobiol       Date:  2015-12-17       Impact factor: 5.590

5.  P53 nuclear stabilization is associated with FHIT loss and younger age of onset in squamous cell carcinoma of oral tongue.

Authors:  Raju Adduri; Viswakalyan Kotapalli; Neha A Gupta; Swarnalata Gowrishankar; Mukta Srinivasulu; Mohammed Mujtaba Ali; Subramanyeshwar Rao; Shantveer G Uppin; Umanath K Nayak; Snehalatha Dhagam; Mohana Vamsy Chigurupati; Murali Dharan Bashyam
Journal:  BMC Clin Pathol       Date:  2014-08-09

6.  TP53 Pro72 allele is enriched in oral tongue cancer and frequently mutated in esophageal cancer in India.

Authors:  Raju S R Adduri; Rajender Katamoni; Ramaswamy Pandilla; Sandeep N Madana; Arun Kumar Paripati; Viswakalyan Kotapalli; Murali Dharan Bashyam
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

7.  Enhancing radiosensitivity of TE1, TE8, and TE 11 esophageal squamous carcinoma cell lines by Hdm2-siRNA targeted gene therapy in vitro.

Authors:  Jalil Pirayesh Islamian; Mohsen Mohammadi; Behzad Baradaran; Alireza Farajollahi; Seyed Mahmoud Reza Aghamiri; Mohammad Asghari Jafarabadi; Hadi Karami; Amir Monfaredan; Dariush Shanehbandi
Journal:  Bioimpacts       Date:  2016-06-28

8.  Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study.

Authors:  L C Hewitt; I Z Inam; Y Saito; T Yoshikawa; A Quaas; A Hoelscher; E Bollschweiler; G E Fazzi; V Melotte; R E Langley; M Nankivell; D Cunningham; W Allum; G G Hutchins; H I Grabsch
Journal:  Eur J Cancer       Date:  2018-03-20       Impact factor: 9.162

9.  Potential Role of Targeting KDR and Proteasome Inhibitors in the Therapy of Esophageal Squamous Cell Carcinoma.

Authors:  Ling Zhang; Xia Niu; Yanghui Bi; Heyang Cui; Hongyi Li; Xiaolong Cheng
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

10.  Occurrence of High Microsatellite-Instability/Mismatch Repair Deficiency in Nearly 2,000 Human Adenocarcinomas of the Gastrointestinal Tract, Pancreas, and Bile Ducts: A Study From a Large German Comprehensive Cancer Center.

Authors:  Alexander Quaas; Jan Rehkaemper; Josef Rueschoff; Aylin Pamuk; Thomas Zander; Axel Hillmer; Janna Siemanowski; Jana Wittig; Reinhard Buettner; Patrick Plum; Felix Popp; Florian Gebauer; Christiane Josephine Bruns; Heike Loeser; Hakan Alakus; Birgid Schoemig-Markiefka
Journal:  Front Oncol       Date:  2021-07-22       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.